MANGALAMBSEMangalam Drugs & Organics LtdMediumPositive
Announced Wed, 29 Apr · 18:30 IST

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 29, 2026 for Shree Rasbihari ....

Pledge ReleasedOwnership Changes View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹28.91
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.0+1.9+0.8+2.8+4.9+7.9+1.5+0.3-2.3
Up moveDown movePending
AI summary

Shree Rasbihari Trading and Investments Private Limited, a promoter entity of Mangalam Drugs & Organics Ltd, disclosed the release of 1,73,000 pledged shares (representing 1.09% of the company's share capital) on March 16, 2026. Prior to the release, the promoter group entity held 1,73,000 shares representing 6.20% of the company's capital, all of which were encumbered. After the release of encumbrance, the post-event encumbered holding stands at zero shares (0% of capital), meaning the entire promoter stake is now free from any pledge or lien. The disclosure was submitted to both BSE and NSE by Smita A. Dhoot, Director, on April 28, 2026 as a revised submission.

Likely market impact

The release of pledge removes a potential overhang on the promoter shareholding, which is positive for minority shareholders as it signals reduced risk of forced selling by lenders. The promoter's effective economic interest and voting rights remain unchanged at 6.20%.